Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-14-004876
Filing Date
2014-11-03
Accepted
2014-11-03 16:16:16
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aldr-10q_20140930.htm 10-Q 1435265
2 EX-31.1 aldr-ex311_201409307.htm EX-31.1 13152
3 EX-31.2 aldr-ex312_201409306.htm EX-31.2 13148
4 EX-32.1 aldr-ex321_201409308.htm EX-32.1 8866
  Complete submission text file 0001564590-14-004876.txt   4452702

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aldr-20140930.xml EX-101.INS 582509
6 XBRL TAXONOMY EXTENSION SCHEMA aldr-20140930.xsd EX-101.SCH 19447
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aldr-20140930_cal.xml EX-101.CAL 34984
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aldr-20140930_def.xml EX-101.DEF 44874
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldr-20140930_lab.xml EX-101.LAB 172866
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldr-20140930_pre.xml EX-101.PRE 124838
Mailing Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011
Business Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011 425-205-2900
ALDER BIOPHARMACEUTICALS INC (Filer) CIK: 0001423824 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36431 | Film No.: 141189665
SIC: 2834 Pharmaceutical Preparations